Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: Special emphasis on using 18F-FDG PET/CT

Clinical Endocrinology

Volumn 72, Issue 4, 2010, Pages 558-563

  Seo, Ji Hyoung ^a   Lee, Sang Woo ^a   Ahn, Byeong Cheol ^a   Lee, Jaetae ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; THYROGLOBULIN ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PREVALENCE; THYROGLOBULIN; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 77749301418     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03693.x     Document Type: Article

References (26)

1. Filesi, M., Signore, A., Ventroni, G. et al. (1998) Role of initial iodine-131 whole body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. Journal of Nuclear Medicine, 39, 1542 1546.
2. Spencer, C.A. (2004) Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. Journal of Clinical Endocrinology and Metabolism, 89, 3702 3704.
3. Rosario, P.W., Maia, F.F., Fagundes, T.A. et al. (2004) Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance. Arquivos Brasileiros de Endocrinologia e Metabologia, 48, 487 492.
4. Bachelot, A., Cailleux, A.F., Klain, M. et al. (2002) Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid, 12, 707 711.
5. Grunwald, F., Kalicke, T., Feine, U. et al. (1999) Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. European Journal of Nuclear Medicine, 26, 1547 1552.
6. 131I whole-body scan. Journal of Nuclear Medicine, 40, 986 992.
7. 18F]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine. Thyroid, 11, 1169 1175.
8. 18F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma. Annals of Surgery, 234, 804 811.
9. Gorges, R., Maniecki, M., Jentzen, W. et al. (2005) Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. European Journal of Endocrinology, 153, 49 55.
10. Chiovato, L., Latrofa, F., Braverman, L.E. et al. (2003) Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Annals of Internal Medicine, 139, 346 351.
11. Rubello, D., Casara, D., Gireffi, M.E. et al. (1992) Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: A prospective study. Journal of Nuclear Medicine, 33, 1478 1480.
12. Adil, A., Jafri, R.A., Waqar, A. et al. (2003) Frequency and clinical importance of anti-Tg auto-antibodies (ATG). Journal of the College of Physicians and Surgeons-Pakistan, 13, 504 506.
13. Chung, J.K., Park, Y.J., Kim, T.Y. et al. (2002) Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clinical Endocrinology, 57, 215 221.
14. Phan, H.T., Jager, P.L., van der Wal, J.E. et al. (2008) The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation. European Journal of Endocrinology, 158, 77 83.
15. Hjiyiannakis, P., Mundy, J. Harmer, C. (1999) Thyroglobulin antibodies in differentiated thyroid cancer. Clinical Oncology, 11, 240 244. (Pubitemid 29425755)
16. Quevedo, I., Campino, C., Rodríguez Portales, J.A. et al. (2002) Antithyroglobulin antibodies in the follow up of patients with differentiated thyroid cancer: residual or relapsing disease markers? Revista Médica de Chile, 130, 167 172.
17. Aras, G., Gültekin, S.S. Küçük, N.O. (2008) The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer. Nuclear Medicine Communication, 29, 880 884.
18. Kim, W.G., Yoon, J.H. Kim, W.B. (2008) Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. Journal Clinical Endocrinology and Metabolism, 93, 4683 4689.
19. 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer. Journal of Nuclear Medicine, 48, 889 895.
20. 18F]-fluorodeoxyglucose standardized uptake values of PET imaging predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas? Laryngoscope, 116, 2133 2137.
21. Smith, R.B., Robinson, R.A., Hoffman, H.T. et al. (2008) Preoperative FDG-PET imaging to assess the malignant potential of follicular neoplasms of the thyroid. Otolaryngology and Head and Neck Surgery, 138, 101 106.
22. Grant, C.S., Thompson, G.B., Farley, D.R. et al. (2008) The value of positron emission tomography in the surgical management of recurrent papillary thyroid carcinoma. World Journal of Surgery, 32, 708 715.
23. Frasoldati, A., Pesenti, M., Gallo, M. et al. (2003) Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer, 97, 90 96.
24. Shammas, A., Degirmenci, B., Mountz, J.M. et al. (2007) F-18 FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer. Journal of Nuclear Medicine, 48, 221 226.
25. Zoller, M., Kohlfuerst, S., Igerc, I. et al. (2007) Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality? European Journal of Nuclear Medicine and Molecular Imaging, 34, 487 495.
26. Spencer, C.A., Takeuchi, M., Kazarosyan, M. et al. (1998) Seurm thyroglobluin autoantibodies: Prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 83, 1121 1127.